Agilon Health (NYSE:AGL) Shares Down 4% – Here’s What Happened

Agilon Health, Inc. (NYSE:AGL)’s share price fell 4% on Monday . The company traded as low as $0.9331 and last traded at $0.9518. 3,496,789 shares were traded during mid-day trading, a decline of 33% from the average session volume of 5,223,832 shares. The stock had previously closed at $0.9910.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on AGL. Barclays reduced their price target on Agilon Health from $1.50 to $1.00 and set an “underweight” rating for the company in a research report on Thursday, November 6th. BTIG Research reissued a “neutral” rating on shares of Agilon Health in a report on Friday, December 12th. Royal Bank Of Canada raised shares of Agilon Health from a “hold” rating to a “moderate buy” rating in a research note on Wednesday, December 3rd. Zacks Research raised shares of Agilon Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, October 21st. Finally, Wells Fargo & Company lowered their target price on shares of Agilon Health from $1.50 to $1.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 5th. Four research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $2.71.

Agilon Health Price Performance

The business’s 50 day moving average is $0.76 and its two-hundred day moving average is $1.05. The firm has a market capitalization of $394.60 million, a PE ratio of -1.27 and a beta of 0.05.

Agilon Health (NYSE:AGL) last released its quarterly earnings results on Tuesday, November 4th. The company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.09). The company had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Agilon Health had a negative return on equity of 75.92% and a negative net margin of 5.24%. Analysts expect that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

A number of large investors have recently added to or reduced their stakes in AGL. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Agilon Health by 5.6% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 105,324 shares of the company’s stock worth $256,000 after purchasing an additional 5,627 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Agilon Health by 3.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock worth $927,000 after buying an additional 7,209 shares during the last quarter. Dynamic Technology Lab Private Ltd boosted its stake in Agilon Health by 28.4% in the first quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock worth $204,000 after buying an additional 10,424 shares in the last quarter. Signaturefd LLC boosted its stake in Agilon Health by 65.1% in the second quarter. Signaturefd LLC now owns 30,479 shares of the company’s stock worth $70,000 after buying an additional 12,018 shares in the last quarter. Finally, Apollon Wealth Management LLC grew its position in Agilon Health by 17.4% during the fourth quarter. Apollon Wealth Management LLC now owns 82,348 shares of the company’s stock valued at $57,000 after acquiring an additional 12,193 shares during the last quarter.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.